Nmr-Based Metabolomic Approaches

To Evaluate The Effects Of Eurycoma

Longifolia Extracts On Rat

Spermatogenesis by Ebrahimi, Forough
 NMR-BASED METABOLOMIC APPROACHES 
TO EVALUATE THE EFFECTS OF EURYCOMA 
LONGIFOLIA EXTRACTS ON RAT 
SPERMATOGENESIS  
 
 
 
 
by 
 
 
FOROUGH EBRAHIMI 
 
 
 
Thesis submitted in fulfillment of the requirements 
for the degree of  
Doctor of Philosophy 
 
 
 
 
 September 2016 
 i 
 
 
 
 
 
 
 
 
To my husband and parents for their unconditional love and support 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ii 
 
ACKNOWLEDGEMENT 
 
My heartiest thanks go to my parents and my husband for their love and having my back 
throughout my PhD project. They supported me emotionally at the moments I was 
desperate and hopeless. Without their support, it was impossible for me to tackle the 
problems I encountered during the study period. I would like to specially thank my 
supervisor Professor Chan Kit Lam for his precious advice and guidance throughout the 
whole study period. I truly appreciate his knowledge and patience in raising me to the 
academic stage I stand today. It was my fortune, honor and pleasure to have Dr. 
Baharudin Ibrahim as my co-supervisor. My sincerest thanks go to him and to another 
co-supervisor of mine, Dr. Vikneswaran Murugaiyah for their invaluable advice and 
encouragement all the time.  
I am grateful to Dr. Teh Chin Hoe who opened my horizons to the wonderful world of 
NMR spectroscopy and guided me constantly. I would like to express my gratitude to Dr 
Low Bin Seng and Dr Ma Hai Qiu for their helpfulness and kindness. I would like to 
thank Dr. Isma Suzyta Ismail and her team in the Animal Research and Service Center, 
USM. 
I would like to extend my gratitude to Professor Yuen Kah Hay and his research team 
especially Mr. Song Thai Goh and Dr. Jia Woei Wong for assisting me with the LC-
MS/MS analysis of my samples. I truly appreciate their help. 
My thanks also goes to Mr. Zahari Othman, the NMR laboratory assistant from the 
School of Chemical sciences for assisting me with NMR-related problems. I also wish to
  iii 
 
thank the helpful staff of the School of Pharmaceutical Sciences for their kindness and 
flexibility in providing me with the facilities and their technical support: Mr. Ahmad 
Zainudin, Mr. Anuar Hassim, Mr. Fisal Jamaludin, Mr. Roseli Hassan, Mr. Selvamani 
Narayan Nair, Mr. Abdul Hamid Ismail, Mr. Syed Mohammed Md. Abdul Kadir, Mr. 
Anuar Apandi Ahmad, Mr. Aizat Hafifi Hafiz Ahmad Sabri, and all the rest of the staff. 
My experience in the world of science would not have been pleasant without my caring 
and helpful colleagues, Wai Lam, Wan Jie, Cheng, Liew, Saiful and Jacky. I wish to 
thank my co-supervisors’ postgraduate team, Fatima, Arwa, Majed and Sultan. Ashfaq 
should be thanked for his great help with the animal study. I wish him and all the rest of 
my friends in the school of Pharmaceutical Sciences all the best of luck throughout their 
life. 
 
 
 
iv 
 
TABLE OF CONTENTS                                 
ACKNOWLEDGEMENT .................................................................................................. ii 
TABLE OF CONTENTS ................................................................................................... iv 
LIST OF TABLES ........................................................................................................... xiii 
LIST OF FIGURES  .......................................................................................................... xv 
LIST OF APPENDICES ................................................................................................ xxiii 
LIST OF ABBREVIATIONS ...................................................................................... xxviii 
LIST OF SYMBOLS ..................................................................................................... xxxi 
ABSTRAK ................................................................................................................... xxxiii 
ABSTRACT ................................................................................................................ xxxvii 
 
CHAPTER ONE:   INTRODUCTION                                                                     
1.1 Infertility as a public health issue                                                                           1 
1.2 Male fertility assessment                                                                                        1 
1.3 Traditional remedies for boosting male fertility                                                    1 
1.4 The necessity of a new approach to E. longifolia analysis and                              3 
the management of fertility  
1.5 NMR-based metabolomics                                                                                     4 
v 
 
1.6 Objectives of the current study                                                                              7 
1.7 Expected outcomes of the current study                                                                8 
 
CHAPTER TWO:   LITERATURE REVIEW                                                            
2.1 Eurycoma longifolia Jack                                                                                   9 
2.1.1   Chemical constituents of E. longifolia                                                    9 
2.1.1(a)   Quassinoids                                                                          11 
2.1.1(b)   Glycoproteins                                                                       12 
2.1.1(b)(i)  Glycoproteins in E. longifolia extract                12  
2.1.1(b)(ii)  Sodium dodecyl sulfate-polyacrylamide         13 
                  gel electrophoresis   
2.1.2 Therapeutic effects of E. longifolia                                                          14 
2.2 Male fertility                                                                                                         15 
2.2.1  Physiology of testis and its functions                                           16 
2.2.2  Steroidogenesis and spermatogenesis                                          16 
2.2.3  Sperm count                                                                                 19 
2.3 Comparison of different ‘OMICS’ platforms                                                      21 
2.4 Metabolomics                                                                                                       22 
2.4.1  Metabolomics technologies                                                          22 
2.4.2  Metabolomics approaches                                                            26 
2.4.2(a) Metabolomic fingerprinting                                 26 
2.4.2(b) Metabolomic profiling                                         26 
vi 
 
2.5 Metabolite identification                                                                                      27 
2.5.1  Metabolite databases                                                                    27 
2.6 Quantitative analysis of metabolites                                                                    28 
2.6.1  Application of quantitative NMR (qNMR)                                  28 
2.6.2  Spectral deconvolution techniques                                               30 
2.7 Plasma metabolomics                                                                                           31 
2.7.1  Carr-Purcell-Meiboom-Gill (CPMG) pulse sequence                  31 
2.7.2  Deproteinization of plasma samples                                             32 
2.8 Statistical analysis                                                                                                33 
2.8.1  Bucketing                                                                                     33 
2.8.2  Scaling                                                                                          34 
2.8.3  Principal component analysis                                                       35 
2.8.4  Partial least squares                                                                      35 
2.8.5  Partial least squares discriminant analysis                                   36 
2.8.6  Orthogonal partial least squares discriminant analysis (OPLS-DA)     37 
2.9 Outline of the current study                                                                                  38 
 
CHAPTER THREE:   MATERIALS AND METHODS 
PART I. NMR-based metabolomic analysis of Eurycoma longifolia extracts 
3.1 Chemicals and reagents for E. longifolia analysis                                               42 
3.2 Plant material                                                                                                       43 
3.3 Preparation of E. longifolia samples for NMR acquisition                                  43 
3.4 NMR data acquisition                                                                                          44 
vii 
 
3.5 NMR experimental conditions                                                                             46 
3.6 Identification of E. longifolia metabolites                                                           48 
3.7 Validated quantification of quassinoids                                                               48 
3.8 Statistical analysis on E. longifolia extract samples                                            49 
3.9 Discriminatory metabolites                                                                                  50 
 
PART II. NMR-based metabolomic analysis of rat urine 
3.10     Chemicals and reagents for urine analysis                                                           51 
3.11 Plant material and extraction protocol                                                                 52 
3.12 SDS-PAGE protocol for the analysis of glycoprotein in E. longifolia extracts   53 
3.12.1  Sample preparation procedure for gel electrophoresis                 54 
3.13 HPLC analysis                                                                                                      54 
3.13.1  Instrumentation                                                                            54 
3.13.2  HPLC method validation                                                              55 
3.14 Animal study experimental procedure                                                                 55 
3.14.1  Sperm collection and motility assessment                                   56 
3.14.2  Sperm count                                                                                 57 
3.14.3  Sperm morphology                                                                       58 
3.15 Urine sample preparation                                                                                     58 
3.16     NMR analysis of urine                                                                                         59 
3.17     Statistical analysis on urine samples                                                                    61 
3.18     LC-MS/MS method validation                                                                             63 
viii 
 
3.19 Sample preparation protocol for LC-MS/MS analysis of urine                           64 
3.20 LC-MS/MS instrumentation                                                                                 64 
3.21 Identification and quantification of eurycomanone and testosterone in urine     65 
 
PART III. NMR-based metabolomic analysis of rat plasma 
3.22 Chemicals and reagents for plasma analysis                                                        66 
3.23 Blood plasma collection                                                                                       66 
3.24 NMR sample preparation, data acquisition and metabolite identification           67 
3.25 Statistical analysis on plasma samples                                                                 69 
 
CHAPTER FOUR:   RESULTS AND DISCUSSION 
PART I. Results and discussion on the NMR-based metabolomic analysis of 
Eurycoma longifolia extracts 
4.1 Plants extraction yields and the identified metabolites of Eurycoma            71 
longifolia extracts                                                                            
4.2 Confirmation of the metabolite identification results through HSQC                 81 
4.3 Limitations of NMR spectroscopy in metabolomic analysis of E. longifolia      81 
4.4 A validated 1H-NMR spectroscopy for the quantification of major   82 
quassinoids in aqueous root extracts of E. longifolia                                          
4.4.1 TSP as the chemical shift reference for the analysis of E. longifolia       84 
   aqueous extracts 
 
ix 
 
4.4.2 Signal deconvolution in the 1H-NMR profiles of E. longifolia               85 
extracts 
4.5 Statistical analysis of metabolomics data derived from the E. longifolia            89 
       aqueous extracts and the corresponding findings                                           
4.5.1  Effect of different integration methods in AMIX                        89 
4.5.2  Effect of different scaling methods in AMIX                              89 
4.5.3  Statistical analysis results of aqueous extracts and                              92 
corresponding detected discriminatory metabolites     
4.6 Significance of statistical approaches in the metabolomic analysis                     98 
 of E. longifolia extracts 
4.7 Parameters causing variations in the NMR spectra of crude E.                         100 
longifolia extracts 
4.8 The contribution of the discriminatory metabolites to the difference                101 
among groups of E. longifolia extracts from different locations 
 
PART II. Results and discussion on the NMR-based metabolomic analysis of urine 
from rats treated with E. longifolia extracts containing different quassinoid levels 
4.9 Detection of 4.3 kDa glycoprotein in the extracts of E. longifolia                    103 
4.10 HPLC method validation and the quantification of                                            105 
quassinoidsbased on the validated method                                     
4.11 Quality of the validated HPLC method                                                              108 
4.12 Sperm analysis results                                                                                        108 
 
x 
 
4.13 Justification on the oral administration doses of E. longifolia                           114 
extracts  
4.14 The efficacy of quassinoids vs. glycoproteins on sperm count increase            114 
4.15 Urine HSQC spectral data and the identified urinary                                        116 
metabolites  
4.16 Statistical analysis and the discriminatory metabolites of rat urine                   118 
4.17 Correlation between urine discriminatory metabolites, sperm count                 125 
and the type of metabolites 
4.18 Justification on relation between the discriminatory metabolites of                  126 
urine and sperm count increase in rats 
4.19 Detection of eurycomanone and testosterone in rat urine                                  130 
4.19.1  Lyophilized urine sample vs. the original urine sample             130 
4.19.2  Eurycomanone detection in urine following the IV                   132 
administration of TAQR extract to rats                        
4.19.3  Aqueous- and organic- phase urine for the presence                 134 
of eurycomanone and testosterone, respectively              
4.20 A validated LC-MS/MS approach for the detection and quantification            136 
 of eurycomanone and testosterone in rat urine  
4.20.1  Detection of eurycomanone and testosterone in SD rat urine    136 
4.20.2  The type of modifier in the LC-MS/MS analysis of urine         145 
4.20.3  LC-MS/MS validation results                                                    146 
 
xi 
 
4.20.4  Determination of eurycomanone and testosterone levels in       148 
rat urine                                                                                               
PART III. Results and discussion on the NMR-based metabolomic 
analysis of plasma from rats treated with E. longifola extracts of 
different quassinoid levels 
4.21 Optimized internal standard for rat plasma analysis                                          153 
4.22 The choice of anticoagulant for the analysis of rat plasma                                154 
4.23 The effect of plasma deproteinization using acetonitrile on the quality            154 
of CPMG spectra 
4.24 Removal of macromolecule particles from rat plasma and                                155 
enhancing the spectrum quality 
4.25 Referencing of plasma Carr-Purcell-Meiboom-Gill (CPMG) spectra               156 
4.26 Detected metabolites of plasma and the statistically significant                        157 
metabolites between the sperm count groups 
4.27 Challenges of plasma metabolite identification                                                 163 
4.28 Discriminatory metabolites of plasma between normal- and high-                   163 
sperm count groups of rats 
CHAPTER FIVE:   CONCLUSION                                                                          167 
CHAPTER SIX:   FUTURE PERSPECTIVES                                                         172 
REFERENCES                                                                                                             175 
APPENDICES                                                                                                              195 
xii 
 
PUBLICATIONS                                                                                                          
LIST OF PRESENTATIONS                                                                                      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xiii 
 
 LIST OF TABLES 
 
 
 
Page 
Table 2.1 The acceptable values of R2 (goodness of fit) and Q2 
(goodness of prediction) based on the type of study 
(Eriksson et al., 2006) 
 
37 
Table 4.1 Soil pH and temperature during harvesting of E. longifolia 
roots from different geographical regions in Malaysia 
 
72 
Table 4.2 Peak assignment, chemical shift and multiplicity of 
detected primary metabolites, based on the analysis of 1H-
NMR and HSQC spectral data of E. longifolia root aqueous 
extracts 
 
74 
Table 4.3 500 MHz 1H-NMR and 13C-NMR spectral data of 
eurycomanone, eurycomanol, 13,21-dihydroeurycomanone 
and eurycomanol-2-O-β-D-glycopyranoside 
 
75 
Table 4.4 NMR method validation including inter-day and intra-day 
precision and accuracy, LOD and LOQ and calibration 
curves for eurycomanone, eurycomanol, eurycomanol-2-O-
β-D-glucopyranoside and 13(21)-dihydroeurycomanone 
 
83 
 
Table 4.5 The amount (relative to TSP, w/w %) of the major 
quassinoids in E. longifolia root aqueous extracts from four 
different states in Malaysia. The results are reported based 
on the mean ± SD. Perak samples, n= 30; Selangor 
samples, n= 5; Kedah samples, n= 5 and  
Terengganu samples, n= 5 
 
88 
Table 4.6 Discriminatory bins and their corresponding particulars 
based on the OPLS-DA model of E. longifolia aqueous 
extracts from different geographical regions. Enol and enol 
glycoside represent eurycomanol and eurycomanol-2-O-β-
D-glycopyranoside, respectively 
 
94 
Table 4.7 HPLC method validation including within-day and 
between day precision and accuracy, LOD and LOQ and 
calibration curves for three quassinoids in E. longifolia 
extracts. Enone, dihydro and epoxy represent 
eurycomanone, 13,21- dihydroeurycomanone and 13α(21)-
epoxyeurycomanone, respectively 
 
106 
 
 
 
 
 
 
 
 
 
 
 
 
xiv 
 
 
 
 
 
 
 
 
 
Table 4.8 Quantification of eurycomanone, 13,21-
dihydroeurycomanone and 13α(21)-epoxyeurycomanone in 
different extracts of E. longifolia using a validated HPLC-
UV system. D stands for day of extraction. The extract 
obtained on D3 of Soxhlet extraction was quassinoid-poor 
Tongkat Ali extract (TAQP). TAQR represents quassinoid-
rich Tongkat Ali extract 
 
107 
Table 4.9 The effect of 48-day oral administration of different 
extracts of Eurycoma longifolia (TA) including TA water 
(TAW), TA quassinoid-poor (TAQP) and TA quassinoid 
rich (TAQR) extracts on male rat epididymial sperm count, 
motility, and morphology. The data are reported based on 
the mean ± SD 
 
109 
Table 4.10 Peak assignment, 1H, 13C chemical shifts and the 
multiplicity of detected urinary metabolites, based on the 
analysis of 1H-NMR and HSQC spectral data of rat urine 
 
118 
Table 4.11 LC-MS/MS method validation including within-day and 
between day precision and accuracy, LOD and LOQ and 
calibration curves for testosterone and eurycomanone 
 
147 
Table 4.12 LC-MS/MS based quantification of eurycomanone in high-
SC group and that of testosterone in both normal- and high-
SC groups; SC signifies sperm count 
 
150 
Table 4.13 Peak assignment, chemical shift and multiplicity of 
detected metabolites of rat plasma at 500 MHz 
 
158 
xv 
 
  
 
 
 
LIST OF FIGURES 
 
 
 
 
 
 
 
Page 
Figure 2.1 Eurycoma longifolia Jack; A the whole plant, B leaves, C 
root and D flowers 
 
10 
Figure 2.2 Basic skeletons of quassinoids 
 
11 
Figure 2.3 The chemical structure of androgens produced in testis 
 
18 
Figure 2.4 Drawing depicting the development stages of 
spermatogenesis in rat germ cells (depicted from Cheng 
and Mruk, 2010) 
 
20 
Figure 3.1 Experimental procedure for E. longifolia sample preparation 
and NMR data acquisition 
 
46 
Figure 3.2 Experimental protocol for rat urine sample preparation and 
NMR data acquisition 
 
60 
Figure 3.3 Experimental protocol for rat plasma sample preparation 
and NMR data acquisition 
 
68 
Figure 4.1 The overlay of 20 replicate 1H-NMR spectra of the 
representative randomly-picked E. longifolia aqueous 
extract for evaluating overtime spectrometer stability. The 
zoomed area indicates the overlay of the corresponding TSP 
signals 
 
73 
Figure 4.2 The comparison of TSP absolute integral values among 4 
randomly selected aqueous extracts of E. longifolia 
(samples 1-4, n= 20). The results are reported based on the 
mean ± SD. The corresponding coefficients of variation are 
0.0138, 0.0237, 0.0170 and 0.0079 for samples 1, 2, 3 and 
4, respectively 
 
73 
Figure 4.3 The chemical structures of A eurycomanone, B 
eurycomanol, C 13,21- dihydroeurycomanone and D 
eurycomanol-2-O-β-D-glycopyranoside 
 
78 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xvi 
 
Figure 4.4 The presence of A eurycomanone (H3, 6.13 ppm, br s; 
125.94 ppm), B eurycomanol (H3, 5.47 ppm, br s; 124.93 
ppm), C 13,21- dihydroeurycomanone (H1, 4.27 ppm, s; 
82.91 ppm) and D eurycomanol-2-O-β-D-glycopyranoside 
(H3, 5.65 ppm, br s; 123.85 ppm) in the representative 
aqueous extracts of Eurycoma longifolia roots from four 
different regions in Malaysia. 
The chemical shifts in the parenthesis signify the 1H-NMR 
signals based on which the identification was done. For 
each quassinoid, the second chemical shift (in ppm) 
belongs to 13C which was extracted from the HSQC spectra 
of the plant samples. 
The letters P, S, K and T on the figures signify the plants 
from Perak, Selangor, Kedah and Terengganu, respectively 
 
79 
Figure 4.5 The overlaid 1H-NMR signals of TSP in the E. longifolia 
aqueous extract samples from four different locations in 
Malaysia. The spectra are labeled with the letters P, S, K 
and T for Perak, Selangor, Kedah and Terengganu samples, 
respectively 
 
85 
Figure 4.6 Deconvolution of H3 signal of A eurycomanone (6.1 ppm, 
br s) and B eurycomanol (5.47 ppm, br s) in the 
representative 1H-NMR spectrum of E. longifolia root 
aqueous extract. The spectrum at the bottom, is the original 
spectrum showing how the NMR signals overlap with each 
other. The spectrum on top only contains the deconvolutd 
signal of H3 
 
87 
Figure 4.7 Comparison of the effect of different integration methods 
on the quality of the PCA models extracted from the 1H-
NMR profiles of Selangor (left) and Terengganu (right) 
samples. A integration to sum of intensities; B integration 
to positive intensities and C  
integration to sum of absolute intensities. The quality of 
each model is assessed by goodness of fit (R2) and 
goodness of prediction (Q2) values which are reported at 
the bottom of each figure. No scaling was performed on 
data 
 
90 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xvii 
 
Figure 4.8 Comparison of the effect of different scaling methods on 
the quality of the PCA models extracted from the 1H-NMR 
profiles of Selangor (left) and Terengganu (right) samples. 
A scaling to biggest bucket; B scaling to total intensities 
and C scaling to reference region (TSP). The quality of 
each model is assessed by goodness of fit (R2) and Q2 
(goodness of prediction) values which are reported at the 
bottom of each figure. All the data were integrated to sum 
of intensities 
 
91 
Figure 4.9 A Principal component analysis (PCA) score plot of E. 
longifolia root aqueous extracts; B Hotelling’s T2 ellipse 
constructed from the PCA score plot. The results are based 
on the 95% confidence interval 
 
93 
Figure 4.10 Score plots of OPLS-DA for 45 1H-NMR profiles of E. 
longifolia root aqueous extracts. Circles for the samples 
from Perak; squares for the samples from Selangor; stars 
for the samples from Kedah; triangles for the samples from 
Terengganu 
 
94 
Figure 4.11 Validation plot for the OPLS-DA model of E. longifolia 
aqueous extracts from different regions. Correlation 
coefﬁcients were calculated between the permuted and 
original class indices. The Y-axis represents R2 (circles) 
and Q2 (squares) 
 
96 
Figure 4.12 Integrated intensity (relative to TSP as the reference for 
each 1H-NMR spectrum) of detected discriminatory 
metabolites from OPLS-DA-extracted VIP plot of E. 
longifolia aqueous extracts from four locations in 
Malaysia. The figure indicates the following chemical shift 
ranges: A choline, B enol glycoside (H3), C enol (H3), D 
enol (H 19), E lactic acid and F succinic acid. P, S, K and 
T stand for Perak, Selangor, Kedah and Terengganu, 
respectively. The significant differences are marked with 
asterisk. * Significant at P<0.05; ** Significant at P<0.01; 
*** Significant at P<0.001. Intensity values are shown 
with the associated standard deviation 
 
97 
Figure 4.13 
 
Slight intersample variations observed in 10 randomly-
picked 1H-NMR spectra of E. longifolia extracts from 
Perak. The H3 signals of eurycomanone (6.09-6.14 ppm) 
in the overlaid samples shows how samples are different 
with respect to chemical shift, line width, signal intensity 
and signal shape 
101 
xviii 
 
Figure 4.14 
 
 
 
 
 
Schiff’s reagent staining of the SDS-Polyacrylamide gel 
for the detection of 4.3 kDa glycoprotein in Tongkat Ali 
water extract (TAW) and quassinoid-poor Tongkat Ali 
(TAW QP, TAQP) samples at three different quantities. 
The spot at almost 44 kDa represents horseradish 
peroxidase (HRP) as the positive control 
 
104 
Figure 4.15 Sperm photomicrographs (x 400) of control (Ctrl.) SD rats 
and the rats treated with 125 mg/kg TAW extract, 125 
mg/kg TAQP extract and 21 mg/kg TAQR extract after a 
48-day treatment. TAW, TAQP and TAQR stand for 
Tongkat Ali water, Tongkat Ali quassinoid-poor and 
Tongkat Ali quassinoid-rich extracts. The average sperm 
count values (x 106/mL/g testis) are 25.35 ± 6.42, 65.90 ± 
26.11, 28.73 ± 17.42 and 68.27 ± 14.96 for Ctrl. and TAW-, 
TAQP- and TAQR-treated groups, respectively 
 
111 
Figure 4.16 One-way ANOVA for sperm count comparison of rats 
treated with TAW (125 mg/kg, 65.9 ± 26.11 ), TAQP (125 
mg/kg, 28.73 ± 17.42) and standardized TAQR (21 mg/kg, 
68.27 ± 14.96) extracts; control group (25.35 ± 6.42) 
* Significant at p<0.05, the results are reported based on 
mean ± SD; n= 6; The treatment doses were adjusted based 
on the quassinoids (mainly eurycomanone) quantification 
results obtained from HPLC analysis of the plant extracts 
and also based on the recent study by Low et al., (2013b) 
 
112 
Fig. 4.17 General categories of sperm morphological defects on 
head, neck and tail found in the sperm photomicrographs of 
rats from control, TAW-treated, TAQP-treated and TAQR-
treated groups. A head defects (from left to right: pinhead, 
flattened head and detached 
head sperm), B neck defect (bent neck) and C tail defect 
(coiled tail) 
 
113 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xix 
 
Figure 4.18 The representative HSQC spectrum of a randomly-picked 
urine sample from the treatment group 4 (TAQR) 
confirmed the existence of urinary metabolites identified 
by 1H-NMR spectra of urine. A The urinary metabolites 
lactic acid (1), alanine (2), acetic acid (3), methylmalonic 
acid (4), succinic acid (5), methylamine (6), dimethylamine 
(7), 2-oxoglutaric acid (8), trimethylamine-N-oxide, 
TMAO (9), guanido acetoacetate (10), creatine (11), N-
methylhydantion (12) and 2-hydroxyglutaric acid (13) 
were detected in the urinary NMR region of 1-4.5 ppm; B 
The urinary metabolites benzoic acid (14), trigonelline (15) 
and formic acid (16) were detected within the chemical 
shift range of 6.5-9.2 ppm 
 
117 
Figure 4.19 OPLS-DA plots of urinary spectra from the rats with 
normal and high sperm count; A OPLS-DA scores plot 
derived from the 1H-NMR spectra of urine samples 
obtained from normal- and high-sperm count rats. Gray 
circle: normal-sperm count group; Black circle: high-sperm 
count group; R2= 0.9516, Q2= 0.8247 B OPLS-DA plot of 
the important peak intensities based on the UVLR analysis. 
Gray circles represent the NMR profiles of normal-sperm 
count group while the black circles indicate those of high-
sperm count group; R2= 0.8015, Q2= 0.7426 
 
119 
Figure 4.20 VIP plot of 69 bins (out of 242 initial bins) with the VIP 
value greater than 1. The horizontal axis indicates the 
chemical shift value corresponding to each bin considering 
the bin width 0.04, e.g., 1.18 represents the bin with the 
chemical shift range of 1.18-1.22 ppm. The error bars show 
the 95 % confidence level 
 
122 
Figure 4.21 Statistical comparison of A Trigonelline (*Significant at 
p<0.001); B Ethanol (*Significant at p<0.001); C Benzoic 
acid (*Significant at p= 0.008) and D the intensity of an 
unknown signal at 3.42ppm (*Significant at p= 0.002). The 
quantitative values are normalized against TSP. The results 
are reported as mean ± SD; significant results based on 
p<0.05 
 
124 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xx 
 
Figure 4.22 Routes by which trigonelline increases testosterone 
bioavailability (adapted from Cormier et al., 1997). The 
mechanism of action is either by trigonelline molecule 
getting attached to testosterone directly at 17-OH position 
(ROUTE 1) or through the formation of a chemical 
modifier after trigonelline undergoes several synthetic 
reactions. Testosterone is then modified at the l7-hydroxy 
position by covalent attachment of the charged chemical 
modifier. The advantage of the chemical modifier is that it 
improves testosterone transport properties and is easily 
hydrolyzed under physiological conditions to release free 
testosterone, where needed (ROUTE 2) 
 
128 
 
Figure 4.23 The 1H-NMR spectra of representative urine sample from 
TAQR-treated group. The spectrum at the bottom belongs 
to the original urine sample, while the one on top is the 
result of the lyophilization of the same urine sample 
 
132 
Figure 4.24 The 1H-NMR spectra of eurycomanone at the bottom and 
those of three rats urine samples (1-3) following the 
intravenous treatment of rats with 10 mg/kg TAQR extract. 
The presence of eurycomanone in urine is shown through 
H3 (6.16 ppm, br s) and H21 (5.62 ppm, s and 5.64 ppm, 
s). The spectra are run at 500 MHz 
 
133 
Figure 4.25 
 
 
 
 
 
 
A The comparison of 1H-NMR profiles of aqueous-phase 
urine in normal- and high- sperm count group of rats for 
the presence of eurycomanone (H3, 6.16 ppm); B The 
comparison of 1H-NMR profiles of organic-phase urine in 
normal- and high- sperm count group of rats for the 
presence of testosterone (H4, 5.76 ppm); SC: sperm count 
 
135 
Figure 4.26 
 
LC chromatograms of A eurycomanone at 3.72 min. and B 
testosterone at 2.74 min 
 
137 
Figure 4.27 The electrospray ionization positive mode (ESI+) mass 
spectrum of eurycomanone (the spectrum at the bottom) 
and the corresponding MS/MS spectrum (the spectrum on 
top) 
 
138 
Figure 4.28 A The electrospray ionization positive mode (ESI+) mass 
spectrum of testosterone (the spectrum at the bottom) and 
the corresponding MS/MS spectrum (the spectrum on top); 
B The possible fragmentation patterns for testosterone 
daughter ions at m/z 97.1 and 108.9 
 
140 
xxi 
 
Figure 4.29 TIC chromatograms of eurycomanone, the aqueous-phase 
urine sample from normal-sperm count (SC) group and that 
of the high-sperm count (SC) group 
 
141 
Figure 4.30 The MS profile of eurycomanone, the representative urine 
sample of the normal-sperm count group and that of the 
high-sperm count group. Unlike the urine samples of the 
high-sperm count group, the samples of normal-sperm 
count group did not contain  eurycomanone and its 
molecular ion 
 
141 
Figure 4.31 The MS/MS profiles of eurycomanone, the representative 
urine sample of the normal-sperm count group and that of 
the high-sperm count group. As expected based on the MS 
profile, no fragmented ion of eurycomanone was detected 
in the samples of normal-sperm count. Although the 
samples of high-sperm count group contained 
eurycomanone, no fragmented ion was detected 
 
142 
Figure 4.32 TIC chromatograms of testosterone, the org-phase urine 
sample from normal-sperm count (SC) group and that of 
the high-sperm count (SC) group 
 
143 
Figure 4.33 The MS profile of testosterone, the representative org-phase 
urine sample of the normal-sperm count group and that of 
the high-sperm count group. Both samples contained 
testosterone 
 
143 
Figure 4.34 
 
 
 
 
The MS/MS profile of testosterone, the representative org-
phase urine sample of the normal-sperm count group and 
that of the high-sperm count group. Both samples 
contained testosterone 
 
144 
Figure 4.35 Comparison of testosterone amount in urine samples of 
normal-and high- sperm count (SC) group of rats. * The 
results are significant at p < 0.05 and reported based on the 
mean ± SD 
 
148 
Figure 4.36 Comparison of line width at half height (W h/2) values of 
the internal standards DSA and TSP peaks in rat plasma 
samples at pH7.4. * The results are significant at p < 0.05 
and reported based on the mean ± SD 
 
153 
 
 
 
 
 
 
 
 
 
xxii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.37 A Principal component analysis (PCA) score plot derived 
from the combined CPMG plasma spectra of normal- and 
high-sperm count rats; B Hotelling’s T2 ellipse constructed 
from the PCA score plot. The results are based on the 95% 
confidence interval 
 
160 
Figure 4.38 OPLS-DA score plot of the first four components from the 
analysis of CPMG NMR spectra of high-sperm count 
group (circles) and those of the normal-sperm count group 
(squares). R2= 0.947 and Q2= 0.892 
 
161 
Figure 4.39 Integrated intensity (relative to DSA as the reference for 
each CPMG spectrum) of detected discriminatory 
metabolites from OPLS-DA-extracted VIP plot of plasma 
samples from low- and high-sperm count group of rats. The 
figures are related to the following discriminatory 
metabolites: A alanine, B lactate, C histidine and D 
ethanol. 
The significant differences are marked with asterisk. * 
Significant at p < 0.05. The bars show the associated 
values of standard deviation 
 
162 
   
xxiii 
 
 LIST OF APPENDICES  
 
 
 
Page 
Appendix 3.1 The required chemicals for the preparation of Dulbecco’s 
Phosphate buffer saline (PBS) following WHO protocol 
(1999) 
 
196 
Appendix 3.2 
 
The required chemicals for the preparation of diluent for 
sperm count and morphology assessment (WHO 1999) 
 
197 
Appendix 3.3 Dilution and conversion factors for counting spermatozoa 
using the Nebauer Haemocytometer WHO, 1999) 
 
198 
Appendix 4.1A The 1H-NMR spectrum of eurycomanone recorded using 
a Bruker AVANCE III 500 MHz spectrometer 
 
199 
Appendix 4.1B The 13C-NMR spectrum of eurycomanone recorded using 
a Bruker AVANCE III 500 MHz spectrometer 
 
200 
Appendix 4.1C The two-dimensional HSQC spectrum of eurycomanone 
recorded using a Bruker AVANCE III 500 MHz 
spectrometer 
 
201 
Appendix 4.2A The 1H-NMR spectrum of eurycomanol recorded using a 
Bruker AVANCE III 500 MHz spectrometer 
 
202 
Appendix 4.2B The 13C-NMR spectrum of eurycomanol recorded using a 
Bruker AVANCE III 500 MHz spectrometer 
 
203 
Appendix 4.2C The two-dimensional HSQC spectrum of eurycomanol 
recorded using a Bruker AVANCE III 500 MHz 
spectrometer 
 
204 
Appendix 4.3A The 1H-NMR spectrum of 13,21-dihydroeurycomanone 
recorded using a Bruker AVANCE III 500 MHz 
spectrometer 
 
205 
Appendix 4.3B The 13C-NMR spectrum of 13,21-dihydroeurycomanone 
recorded using a Bruker AVANCE III 500 MHz 
spectrometer 
 
206 
Appendix 4.3C The two-dimensional HSQC spectrum of 13,21-
dihydroeurycomanone recorded using a Bruker 
AVANCE III 500 MHz spectrometer 
 
207 
Appendix 4.4A The 1H-NMR spectrum of eurycomanol-2-O-β-D- 
glycopyranoside recorded using a Bruker AVANCE III 
500 MHz spectrometer 
208 
xxiv 
 
Appendix 4.4B The 13C-NMR spectrum of eurycomanol-2-O-β-D-
glycopyranoside recorded using a Bruker AVANCE III 
500 MHz spectrometer 
 
209 
Appendix 4.4C The two-dimensional HSQC spectrum of eurycomanol-2-
O-β-D-glycopyranoside recorded using a Bruker 
AVANCE III 500 MHz spectrometer 
 
210 
Appendix 4.5 The BBIOREFCODE 2 match of the representative 1H-
NMR spectrum of E. longifolia extract (the spectrum on 
top) with that of alanine (the spectrum at the bottom) 
proves the presence of alanine in the plant extracts 
 
         211 
Appendix 4.6A The representative 1H-NMR spectrum of E. longifolia 
root aqueous extract from Perak together with the 
identified metabolites: 1 Methylsuccinic acid, 2 enone, 
dihydro enone (H19), 3 lactate, 4 alanine, 5 acetic acid, 6 
enone, dihydro enone (H18), 7 succinic acid, 8 choline, 9 
syringic acid, 10 enone, enol, enol glycoside (H12), 11 
dihydro (H1), 12 enone (H1), 13 β- glucose and/or enol 
glycoside (H1’), 14 quassinoids (H15), 15 α- glucose, 16 
enol (H3), 17 enone, enol, enol glycoside (H21), 18 
enone (H3), 19 fumaric acid, 20 tyrosine, 21 
tyrosine/syringic acid, 22 phenylalanine, 23 formate. 
Enone, enol, dihydro and enol glycoside signify 
eurycomanone, eurycomanol, 13,21-
dihydroeurycomanone and eurycomanol-2-O-β-D-
glucopyranoside, respectively 
 
212 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xxv 
 
Appendix 4.6B 
 
 
 
 
 
 
 
The representative HSQC spectrum of a randomly-
picked E. longifolia root aqueous extract from Perak 
confirmed the existence of plant metabolites identified by 
1H-NMR spectra: 1 α- Glucose, 2 alanine, 3 formic acid, 
4 succinic acid, 5 methylsuccinic acid, 6 fumaric acid, 7 
lactic acid, 8 syringic acid, 9 choline, 10 eurycomanone 
H3,11 eurycomanol H3, 12 13,21- dihydroeurycomanone 
H1, 13 eurycomanol-2-O-β-D-glucopyranoside H3, 14 
phenylalanine, 15 tyrosine, 16 acetic acid, 17 
eurycomanone, 13,21-dihydro eurycomanone H19, 18 
eurycomanone, eurycomanol, eurycomanol-2-O-β-D-
glucopyranoside H12, 19 eurycomanone H1, 20 β- 
Glucose, 21 eurycomanol-2-O-β-D-glucopyranoside H1’, 
22 eurycomanone, eurycomanol, 13,21-dihydro-
eurycomanone, eurycomanol-2-O-β-D-glucopyranoside 
H15, 23 eurycomanone, eurycomanol, eurycomanol- 
2-O-β-D-glucopyranoside H21 and 24 eurycomanone, 
13,21-dihydroeurycomanone H18. The same metabolites  
existed in the samples of Selangor, Kedah and 
Terengganu 
 
213 
Appendix 4.7 
 
 
 
 
Sperm count of individual rats (SC: Sperm Count, The 
first digit in the “Rat” column, signifies the treatment 
group, while the second digit represents the rat number, 
e.g. 35 indicates rat number 5 from treatment group 3 
(TAQP)). Sperm count group was assigned based on the 
median value of normal epididymal SC in control rats 
obtained in our study, which is (25.35 ± 6.42) x 106/mL/g 
testis and also the results from sperm count comparison 
of four experimental groups in which TAQP-treated and 
control groups were not significantly different. As a 
result, TAQP-treated and control groups were labeled as 
normal-SC group (group 1), while group 2 was 
considered to be high-SC group (including TAW- and 
TAQR-treated rats) 
 
214 
Appendix 4.8 Overlaid 1H-NMR spectra of TAW, TAQP and TAQR 
extracts to check for the presence of trigonelline, benzoic 
acid, ethanol, alanine and the NMR signal at 3.42 ppm. A 
no trigonelline was observed at 8.82 and 9.12 ppm; B no 
ethanol was observed at 1.18 ppm; C no benzoic acid 
was observed at 7.54 and 7.86 ppm; D no alanine was 
observed at 1.46 ppm; E no signal at 3.42 ppm was 
detected 
 
215 
   
xxvi 
 
Appendix 4.9 
 
Correlation matrix between sperm count (SC) and the 
discriminatory metabolites of normal- and high-sperm 
count groups. Sperm count is positively correlated with 
trigonelline (trig), alanine (Ala), benzoic acid and the 
unknown metabolite (X) levels, while it is negatively 
related to ethanol (EtOH) level. r represents correlation 
coefficient and p is the significance 
 
216 
Appendix 4.10 1H-NMR and 13C-NMR spectral assignment of 
eurycomanone (dissolved in deuterated phosphate buffer) 
and testosterone (dissolved in CD3OD) based on the 
1H-
NMR and HSQC spectra run on a Bruker AVANCE III 
spectrometer at 500 MHz 
 
217 
Appendix 4.11 The overlaid 1H-NMR spectra of original and freeze-
dried rat urine. The expanded regions of the spectra 
represent the new metabolites (allantoin, glycolic acid, 
sarcosine and L-glycine) which can only be detected in 
the freeze-dried urine samples 
 
218 
Appendix 4.12 The CPMG spectrum of the rat original plasma (the 
spectrum on top) and that of the rat deproteinized plasma 
with acetonitrile (the spectrum at the bottom). A NMR 
regions 0.8-1.6 ppm; B NMR regions 1.85-2.85 ppm; C 
NMR regions 3.04-3.78 ppm and D NMR regions 4.6-5.3 
ppm 
 
220 
Appendix 4.13 The representative HSQC spectrum of a randomly-
picked plasma sample from the control group confirmed 
the existence of metabolites identified by CPMG spectra 
of plasma. The detected metabolites are as follows: 
Ethanol (1), lactate (2), alanine(3), VLDL/LDL (4), 
VLDL/LDL (5), triacylglycerols (6), free EDTA (7), 
esterified  cholesterol (8), lactate (9), β- glucose (10), α- 
glucose (11), lipid HC=CH (12), lipid HC=CH (13), 
triacylglycerols (14), triacylglycerols (15), 
triacylglycerols (16), creatinine (17), 3- hydroxybutiric 
acid (18), CaEDTA2- (19), MgEDTA2- (20), CaEDTA2- 
(21), methanol (22), free EDTA (23), tyrosine (24) and 
succinic acid (25) were detected in the plasma NMR 
Region 0.8-5.5 ppm. The above-mentioned metabolites 
exist in all plasma samples 
 
221 
   
 
 
 
 
 
 
xxvii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix i Pre-viva presentation certificate 
 
222 
Appendix ii The Animal Ethics Committee (AEC) approval 
 
223 
Appendic iii 
 
Plagiarism screening result 224 
Appendix iv Certificate of best poster presentation award in the 
international conference on natural products (ICNP) 
2013 
 
225 
Appendix v Certificate of best poster presentation award (3rd place) in 
the Metabolomics conference 2012 
 
226 
xxviii 
 
                                         LIST OF ABBREVIATIONS                                       
ACN  acetonitrile  
APS  ammonium persulfate  
CD3OD deuterated methanol 
CO2  carbon dioxide 
dd H2O distilled deionized water 
DSA  4,4-dimethyl-4-silapentane-1-ammonium trifluoroacetate 
EtOH  ethanol 
HRP  horseradish peroxidase 
KOD  deuterated potassium (kalium) hydroxide 
MeOH  methanol 
NaHCO3 sodium bicarbonate 
NaN3  sodium azide  
NaOD  deuterated sodium hydroxide 
PBS  phosphate buffered saline 
SDS  sodium dodecyl sulfate 
TCA  trichloroacetic acid  
TEMED tetramethylethylenediamine  
Tris-HCl tris (hydroxymethyl) aminomethane hydrochloric acid 
TSP  sodium 3- (trimethylsilyl) propionate- 2,2,3,3- d4 
AMIX   analysis of mixtures 
APCI  atmospheric pressure chemical ionization  
BBO  broadband observe 
xxix 
 
13C  carbon 
D1  relaxation delay 
Dept-Q distorsionless enhancement by polarization transfer-quaternary 
DS  number of dummy scans 
ESI+  electron spray ionization positive mode 
FID  free induction decay 
FT  Fourier transformation 
GC-MS gas chromatography-mass spectrometry 
1H  proton 
HPLC  high performance liquid chromatography 
HPLC-UV high performance liquid chromatography- ultra violet 
HSQC  heteronuclear single quantum coherence 
LB  line broadening 
LC-MS liquid chromatography-mass spectrometry 
LC-MS/MS liquid chromatography-mass spectrometry/mass spectrometry 
LOD  limit of detection 
LOQ  limit of quantification 
MS  mass spectrometry 
NOESY nuclear Overhauser effect spectroscopy 
NS  number of scans 
PC  principal component 
PCA  principal component analysis 
PDA  photodiode array detector 
xxx 
 
RT  room temperature 
SD  standard deviation 
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SIMCA soft independent modeling of class analogy 
SRM  single reaction monitoring 
TAQP  Tongkat Ali quassinoid poor 
TAQR  Tongkat Ali quassinoid rich 
TAW  Tongkat Ali water 
TIC  total ion chromatogram 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xxxi 
 
LIST OF SYMBOLS 
br s  broad singlet 
br d  broad doublet 
br t  broad triplet 
d  doublet 
D1  relaxation delay 
dd  doublet of doublet 
dt  doublet of triplet 
td  triplet of doublet 
Hz  Hertz 
J  coupling constant 
kDa  kilodalton 
m  multiplet 
m/z  mass over charge 
MHz  mega hertz 
ng  nanogram 
p1  pulse width 
ppm  part per million 
SSB  shifted sine bell 
δH  proton chemical shift 
δC  carbon chemical shift 
1D  one dimensional 
2D  two dimensional 
xxxii 
 
r2  coefficient of determination 
v/v  volume over volume 
w/v  weight over volume 
w/w  weight over weight 
 xxxiii 
 
PENDEKATAN METABOLOMIK BERDASARKAN NMR UNTUK 
MENILAI KESAN EKSTRAK EURYCOMA LONGIFOLIA KE ATAS 
SPERMATOGENESIS TIKUS 
 
ABSTRAK 
Eurycoma longifolia (Tongkat Ali, TA) dikenali untuk meningkatkan kesuburan 
lelaki dan libido. Suatu analisis metabolomik analisis berasaskan resonans magnetik 
nuklear (NMR) dikombinasi dengan kaedah kimometrik termaju telah dibangunkan, 
divalidasikan dan digunakan serentak untuk pengenalan dan kuantifikasi serentak 
metabolit dalam E. longifolia dan cecair mamalia (air kencing dan plasma tikus). Suatu 
profil umum ekstrak akueus yang diperolehi daripada 30 sampel di Perak, Malaysia 
telah ditentukan untuk metabolit terutamanya bagi kuasinoid bioaktif eurikomanon, 
eurikomanol, 13,21-dihidroeuricomanon dan euricomanol-2-O-β-D-glikopiranosida. 
Profil rujukan kemudian dibandingkan dengan ekstrak akueus yang lain dari Selangor, 
Kedah dan Terengganu untuk menyiasat sebarang metabolit diskriminasi berkaitan 
dengan lokasi dan variasi seperti suhu alam sekitar dan pH tanah. Satu lagi kajian adalah 
berkaitan dengan analisis NMR pada air kencing tikus untuk menyiasat sebarang 
korelasi antara metabolit didiskriminasi dengan status bilangan sperma (SC) berikutan 
rawatan tikus dengan pelbagai kandungan kuasinoid dalam air (TAW, 125 mg/kg), 
Tongkat Ali kurang kandungan kuasinoid (TAQP, 125 mg/kg) dan ekstrak kuasinoid 
yang kaya dengan Tongkat Ali (TAQR, 21 mg/kg). Suatu peningkatan 6-kali ganda dos 
TAW, sama dengan TAQP dalam kepekatan kuasinoid, telah diadministrasi untuk 
menyiasat sama ada sebatian dalam kedua-dua ekstrak yang bertanggungjawab bagi 
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peningkatan dalam SC tikus. Tikus-tikus itu kemudian dikategorikan ke dalam 
kumpulan SC normal dan tinggi berdasarkan nilai median rujukan bagi tikus SC yang 
normal. Profil NMR air kencing kumpulan SC normal dan tinggi telah diperiksa untuk 
diskriminasi metabolomik. Tambahan lagi, keputusan rawatan yang sama pada profil 
NMR plasma tikus telah disiasat. Bahagian terakhir kajian bertujuan bagi penemuan 
penanda bio kesuburan daripada metabolit air kencing dan plasma. Profil min ekstrak 
akueus E. longifolia mengandungi α-glukosa, alanina, fenilalanina, tirosina, kolina, asid 
formik, suksinik, metilsuksinik, fumarat, syringik, laktik dan asid asetik dan juga 
eurikomanon, eurikomanol, 13,21-dihidroeuricomanon dan euricomanol-2-O-β-D-
glikopiranosida. Profil metabolomik kuantitatif akar E. longifolia tidak berbeza 
berdasarkan suhu dan pH tanah. Kuantitatif NMR yang divalidasikan (qNMR) dengan 
pastinya menentukan tahap kuasinoid dalam ekstrak akueus E. longifolia, menunjukkan 
eurikomanon (% w/w ± SD) dengan kepekatan kuasinoid yang paling tinggi pada julat 
5.984 ± 1.949 to 7.752 ± 2.892 dan tidak berbeza secara statistik dalam sampel di empat 
lokasi. Sebaliknya, sampel dari lokasi yang berbeza menunjukkan kepekatan yang 
berbeza secara statistik untuk kolina, euricomanol, euricomanol-2-O-β-D-
glikopiranosida, asid laktik dan succinik. Haiwan yang dirawat dengan TAW dan TAQR 
mempunyai bilangan sperma jauh lebih tinggi dan signifikan berbanding dengan dua 
kumpulan lain. Nilai SC (x106/mL/g testis) adalah 25.35 ± 6.42, 65.9 ± 26.11, 28.73 ± 
17.42 dan 68.27 ± 14.96 untuk masing-masing kumpulan kawalan, dirawat dengan 
TAW, dirawat dengan TAP dan dirawat dengan TAQR. Daripada analisis air kencing, 
paras trigonelina, asid benzoik dan alanina meningkat dengan signifikan dalam 
kumpulan SC tinggi berbanding dengan yang SC normal, manakala paras etanol 
xxxv 
 
menurun secara statistik dalam kumpulan SC tinggi. Berdasarkan data literatur, 
perubahan paras metabolit diskriminasi berkorelasi dengan paras testosteron yang 
berbeza dalam sampel air kencing, selepas rawatan dengan ekstrak E. longifolia yang 
mengandungi kepekatan kuasinoid yang berbeza. Bukti lanjut diperolehi dengan 
mengukur paras testosteron dalam kencing tikus. Fasa organik (org) air kencing, kaya 
dengan testosteron, telah diperolehi daripada air kencing yang diekstrak dengan 
dietileter. Air kencing fasa organik dan berair masing-masing dianalisis dengan LC-
MS/MS untuk testosteron dan eurikomanon (sebagai kuasinoid yang paling banyak). 
Kehadiran eurikomanon (hanya dalam kumpulan SC tinggi) telah terbukti dalam fasa 
akueus (aq) air kencing dari puncak isotop [M+H]+ pada m/z 409.02. Testosteron telah 
dikenal pasti dalam kumpulan SC normal dan tinggi dengan ion molekul pada m/z 289.2 
[M+H]+ dan ion yang terserpih pada m/z 96.8 and 108.8. Jumlah testosteron (%w/v) 
dalam kumpulan SC tinggi adalah 2.2 kali ganda lebih tinggi daripada SC normal. 
Analisis statistik plasma tikus juga mendedahkan peningkatan paras alanina, laktat dan 
histidina dalam kumpulan SC tinggi berbanding dengan kumpulan SC normal. Walau 
bagaimanapun, paras etanol menurun dengan signifikan dalam kumpulan SC tinggi. 
Metabolit diskriminasi yang sama telah ditemui dalam plasma seperti yang ditemui 
dalam air kencing. Kesimpulannya, profil metabolomik piawai dari sampel Perak telah 
diperolehi sebagai rujukan. Sampel dari Perak dan yang berada di tiga lokasi yang 
berlainan telah didiskriminasi mengikut paras metabolit mereka. Keberkesanan 
kuasinoid pada peningkatan dalam jumlah sperma telah disahkan oleh peningkatan paras 
kuasinoid dan testosteron air kencing, bersama-sama dengan beberapa metabolit primer 
seperti yang dinyatakan di atas. Pendekatan metabolomik berdasarkan NMR telah 
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memberikan penanda bio air kencing dan plasma yang dikaitkan dengan peningkatan 
jumlah sperma, dan mempunyai potensi untuk penilaian status kesuburan lelaki tanpa 
memerlukan sampel air mani. 
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NMR-BASED METABOLOMIC APPROACHES TO EVALUATE THE 
EFFECTS OF EURYCOMA LONGIFOLIA EXTRACTS ON RAT 
SPERMATOGENESIS  
 
ABSTRACT 
Eurycoma longifolia (Tongkat Ali, TA) is known for boosting male fertility and 
libido. A nuclear magnetic resonance (NMR)-based metabolomics analysis in 
combination with advanced chemometric methods was developed, validated and applied 
for the simultaneous identification and quantification of metabolites in E. longifolia and 
mammalian fluids (rat urine and plasma). A general profile of the aqueous extract 
derived from 30 samples in Perak, Malaysia was established for metabolites especially 
for the bioactive quassinoids of eurycomanone, eurycomanol, 13,21-
dihydroeurycomanone and eurycomanol-2-O-β-D-glycopyranoside. The reference 
profile was then compared with other aqueous extracts from Selangor, Kedah and 
Terengganu to investigate any discriminatory metabolites with respect to location and 
variations such as environmental temperature and soil pH. Another study dealt with the 
NMR analysis of rat urine to investigate any correlation of the discriminated metabolites 
with the sperm count (SC) status following the treatment of rats with varying quassinoid 
content in water (TAW, 125 mg/kg), quassinoid-poor Tongkat Ali (TAQP, 125 mg/kg) 
and quassinoid-rich Tongkat Ali (TAQR, 21 mg/kg) extracts. A 6-fold increase in dose 
of TAW, equal with TAQP in concentration of quassinoids, was administered to 
investigate whether the compounds in the two extracts were responsible for the increase 
in rat SC. The rats were then categorized into normal- and high-SC groups following the 
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reference median value of normal rat SC. The urine NMR profiles of the normal- and 
high-SC groups were next examined for metabolomic discrimination. In addition, the 
results of the same treatment on the rat plasma NMR profiles were investigated. The last 
part of study aimed at the fertility biomarker discovery of the urine and plasma 
metabolites. The E. longifolia aqueous extract general profile contained α- glucose, 
alanine, phenylalanine, tyrosine, choline, formic, succinic, methylsuccinic, fumaric, 
syringic, lactic and acetic acids and also eurycomanone, eurycomanol, 13,21-
dihydroeurycomanone and eurycomanol-2-O-β-D-glycopyranoside. The quantitative 
metabolomic profiles of E. longifolia roots were not different with respect to 
temperature and soil pH. The validated quantitative NMR (qNMR) reliably determined 
the quassinoid levels in E. longifolia aqueous extracts, showing eurycomanone (% w/w 
± SD) with the highest quassinoid concentration at a range of 5.984 ± 1.949 to 7.752 ± 
2.892 and not statistically different in the samples at the four locations. In contrast, the 
samples from different locations were statistically different in concentration of choline, 
eurycomanol, eurycomanol-2-O-β-D-glycopyranoside, lactic and succinic acids. TAW- 
and TAQR-treated animals had significantly higher sperm number compared to the other 
two groups. The SC values (x106/mL/g testis) were 25.35 ± 6.42, 65.9 ± 26.11, 28.73 ± 
17.42 and 68.27 ± 14.96 for control, TAW-treated, TAQP-treated and TAQR-treated 
groups, respectively. From the urine analysis, trigonelline, benzoic acid and alanine 
levels significantly increased in high-SC group compared to the normal-SC one, 
whereas the ethanol level statistically decreased in high-SC group. Based on the 
literature data, the altered level of discriminatory metabolites correlated with the 
different levels of testosterone in urine samples, following the treatment with E. 
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longifolia extracts containing different quassinoid concentration. Further evidence was 
obtained by measuring testosterone level in rat urine. The organic-phase (org) urine, rich 
in testosterone, was obtained from the diethylether extracted urine. The organic and 
aqueous phase urine were analyzed by LC-MS/MS for testosterone and eurycomanone 
(as the most abundant quassinoid), respectively. The presence of eurycomanone (only in 
high-SC group) was proven in aqueous-phase (aq) urine by the isotope peak [M+H]+ at 
m/z 409.02. Testosterone was identified in normal- and high-SC groups displaying the 
molecular ion at m/z 289.2 [M+H]+ and the fragmented ions at m/z 96.8 and 108.8. The 
testosterone amount (% w/v) in the high-SC groups was 2.2 fold higher than that of the 
normal-SC. The statistical analysis of rat plasma also revealed the increased levels of 
alanine, lactate and histidine in the high-SC group compared to the normal-SC group. 
However, the ethanol level significantly decreased in the high-SC group. Similar 
discriminatory plasma metabolites as those of urine were found. In conclusion, a 
standardized metabolomic profile of Perak samples was obtained as a reference. The 
samples in Perak and those in three other locations were discriminated according to their 
metabolite levels. The efficacy on the increase in sperm count of the quassinoids was 
confirmed by the increase in urinary quassinoid and testosterone levels, together with 
some of the above-mentioned primary metabolites. The NMR-based metabolomic 
approach has provided urine and plasma biomarkers associated with an increase in 
sperm count, and has potential for the evaluation of male fertility status without 
requiring semen sample. 
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CHAPTER ONE 
INTRODUCTION 
1.1 Infertility as a public health issue 
Infertility, defined as the inability of a couple to conceive after a year of frequent 
unprotected intercourse, is a worldwide health issue influencing nearly up to one in ﬁve 
couples during reproductive age (Chamley and Clarke, 2007). Male infertility 
contributes to an almost 50 % of all cases of infertility across the globe and is the most 
difﬁcult form of infertility to cure (Irvine, 1998). 
 
1.2 Male fertility assessment 
The traditional method of male fertility assessment is mainly based on the analysis of 
sperm count, morphology and motility on the semen sample provided by subjects 
through masturbation (Guzick et al., 2001). Despite the availability and the effectiveness 
of the advanced conventional methods for fertility evaluation through semen analysis 
and given the inconvenience felt by subjects during masturbation, there is still a high 
demand for a fast, non-invasive and accurate approach to evaluate fertility without 
requiring semen sample. 
 
1.3 Traditional remedies for boosting male fertility 
Medicinal plants are non-directed therapy, easy to collect and less expensive compared 
to prescription medications. Consequently, many people have been attracted to such 
remedies. There are natural remedies becoming extensively popular in boosting fertility 
and serving as aphrodisiac supplements (Rowland and Tai, 2003). 
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Plants such as Eurycoma longifolia, Smilax myosotiflora, Polyalthia bullata, Labisia 
pumila, Terminalia catappa and Rafﬂesia sp. have been claimed to possess aphrodisiac 
properties in Malay traditional medicine. However, the aphrodisiac properties of only E. 
longifolia (Ang et al. 2000) and T. catappa (Ratnasooriya and Dharmasiri, 2000) have 
been scientifically proven. Roots of Eurycoma longifolia (E. longifolia, Tongkat Ali, 
TA), from the family of Simaroubaceae, have been also traditionally used for treating 
various ailments including body aches, dysentery and glandular swelling (Darise et al., 
1982). In general, plant phytochemicals are among either primary or secondary 
metabolites. A primary metabolite is directly involved in normal growth, development 
and reproduction. It performs a physiological function such as an intrinsic function. 
Many organisms or cells contain primary metabolites. The structural variety of such 
metabolites is rather limited to a set of compound classes such as carbohydrates, amino 
acids, organic and fatty acids. In contrast, secondary metabolites are not involved in 
primary life supporting functions. Instead, they usually have important ecological 
functions. They mainly include nucleosides, peptides, alkaloids, terpenoids and 
polyphenols (Wink, 2003; Ratcliffe and Shachar-Hill, 2006). 
E. longifolia consists of a variety of phytochemicals, one of the most important of which 
is quassinoids. Quassinoids are highly oxygenated triterpenes and the major secondary 
metabolites indigenous only to the plants from the Simaroubaceae family which are 
widely researched. The other secondary metabolites of the plant, however, have not been 
extensively studied. A wide range of in vitro pharmacological properties, such as 
antimalarial (Chan et al., 2005), antiulcer (Tada et al., 1991) and also cytotoxic 
properties against human cell lines (Kardono et al., 1991) has been reported on 
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quassinoids. More importantly, the studies by Wahab et al. (2010) and Chan et al. 
(2009) on rat models proved the efficacy of E. longifolia root extracts on 
spermatogenesis and sperm quality. The water-soluble extract of E. longifolia root 
improved sperm quality in infertile patients and led to 14.7% spontaneous pregnancies 
(Tambi and Imran 2010; Tambi et al., 2012). Such findings, in general, cast doubt on the 
efficacy of E. longifolia and quassinoids, especially on male fertility. 
 
1.4 The necessity of a new approach to E. longifolia analysis and the 
management of fertility 
Due to the fact that E. longifolia has a myriad of pharmacological effects, specially 
fertility boosting properties, a robust and accurate approach is required for the 
simultaneous identification and quantification of the plant phytochemicals particulary its 
active constituent, quassinoids. The simultaneous identification of primary and 
secondary metabolites of E. longifolia will create a general profile which can serve as a 
reference for the metabolomic comparison of plants being exposed to different 
variations with respect to the region of origin, age, soil pH and environmental variations 
such as temperature. Moreover, the overall profile can be referred to in the future studies 
on E. longifolia metabolomic analysis. 
The lack of a fast, non-invasive and robust method for the evaluation of sperm quality 
and male fertility status has created a big challenge in the management of male fertility. 
To overcome such limitation, a new field of science known as metabolomics has been 
emerged. One of the functions of metabolomics is to analyze body fluids (e.g. urine and 
plasma, etc.) to create a cost-effective and informative means of measuring related 
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metabolites of different health-related issues such as male fertility. Metabolomics is the 
study of a group of small molecules, known as metabolites, representing functional 
phenotype in a cell, tissue, organ or organism (Rochfort, 2005; Hollywood et al., 2006). 
There are other branches of “omics” such as transcriptomics or proteomics which 
regulate metabolic fluxes. However, metabolome, rather than transcriptome and/or 
proteome, is closer to the phenotype (ter Kuile and Westerhoff, 2001). Although 
alteration in the level of individual enzymes does not have much impact on metabolic 
fluxes, it significantly affects the level of individual metabolites. As a result, 
metabolomics can provide richer and more useful information at a lower cost compared 
to genomics, transcriptomics and proteomics (Raamsdonk et al., 2001).  
 
1.5 NMR-based metabolomics 
Nuclear magnetic resonance (NMR) spectroscopy combined with the statistical analysis 
approaches has been extensively used in the metabolomic analysis of plants and 
biological fluids including urine and plasma. It has been employed in plant sciences 
mostly for the purpose of quality control, detecting the biomarkers of plant diseases and 
studying the effect of different environmental conditions and regions of origin on plant 
metabolomic profile. 
Brassica rapa has nutritional and health beneﬁts due to its high content of antioxidant 
metabolites (phenolics, ﬂavonoids, vitamins C and E). Abdel-Farid et al. (2007) used an 
NMR-based metabolomic approach to investigate the metabolic discrimination of 
different cultivars and ages of Brassica rapa leaves. In another study, 1H-NMR 
spectroscopy was used to acquire the metabolite fingerprints of two sunflower genotypes 
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(Kruger et al., 2008). A fast and sensitive 1H-NMR-based metabolomic profiling of 
deuterated methanol-D2O buffer extracts of transgenic tomato flesh was performed by 
Fatma et al. (2012). The same approach was used by Kim et al. (2010) for the 
discriminatory analysis of 11 South American Ilex species. A clear separation between 
species was achieved and finally resulted in four distinct classes with respect to 
metabolomic similarities. High resolution magic angle spinning-1H-NMR (HRMAS-
NMR) spectroscopy was employed by Ritota et al. (2012) to analyze red and white 
varieties of garlic (Allium sativum L.) collected in different geographical regions in Italy, 
in order to address the traceability issue and identify the discriminatory metabolites of 
different varieties and origins. Plants which have undergone different type of treatments 
can also be analyzed with NMR-based metabolomics approaches (Liang et al., 2006). 
Pereira et al. (2014) performed the metabolomic analysis of lettuce (Lactuca sativa L.) 
leaves to characterize metabolic variations during exposure to mancozeb and the impact 
of variations on plant metabolism. 
Metabolomics studies have been conducted on E. longifolia using other technologies 
except NMR. LC-MS/MS-based secondary metabolomic analysis of E. longifolia 
aqueous extracts from two locations in Malaysia (Perak and Pahang) was investigated 
by Chua et al. (2011). Zaini et al. (2016) reported a solid phase extraction-liquid 
chromatography (SPE-LC) approach for the fingerprinting of E. longifolia roots. A more 
comprehensive and straightforward metabolomics approach using NMR was studied in 
the current research. Enough number of E. longifolia aqueous extracts from Perak were 
used to establish a metabolomic profile of primary metabolites and major biologically 
active quassinoids. The aqueous extracts of Perak and three other locations (Selangor, 
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Kedah and Terengganu) were then compared using chemometric tools for the 
discriminatory metabolites. 
The above-mentioned facts on the health promoting effects of E. longifolia (especially 
fertility improvement) (Section 1.3) and the informative nature of NMR-based 
metabolomics made us develop a validated approach to establish a mean reference 
profile of the 30 plant aqueous extracts from Perak for metabolites, particularly the 
major biologically active quassinoids due to their large number of pharmacological 
effects discussed in Section 1.3. The potential of the approach for distinguishing E. 
longifolia roots from different geographical locations in Malaysia (Perak, Selangor, 
Kedah and Terengganu) and of different environmental conditions (soil pH and 
temperature) was also assessed. A quantitative NMR (qNMR) method was then 
developed for the simultaneous determination of the discriminatory metabolite levels. 
In pursuit of a new method for evaluating male fertility without requiring semen 
analysis, an animal experimental procedure was designed in which rats were treated with 
variable content of quassinoids in TA extracts such as the water (TAW, 125 mg/kg), 
quassinoid-poor TA (TAQP, 125 mg/kg) and quassinoid-rich TA (TAQR, 21 mg/kg) 
extracts. TAW and TAQR extracts contained same amount of quassinoids, while TAQP 
extract was purposely depleted of quassinoids. The effect of quassinoids on sperm count 
(SC) increase was evaluated and the animals were then classified into normal- and high- 
SC groups considering the reference median value of normal rat SC. An NMR-based 
metabolomic approach was then applied on urine samples of the normal- and high-SC 
groups to detect discriminatory metabolites. Furthermore, the discriminatory metabolites 
of plasma were also investigated following the same treatment on the rats. The 
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discriminatory metabolites of urine and plasma may be considered as the potential 
biomarkers for male fertility evaluation without requiring semen analysis. Such an 
approach may be applicable to human for assessing male fertility status.  
 
1.6 Objectives of the current study 
The aims and objectives of the present study are as follows: 
1. To develop a standardized mean NMR profile for the identification of primary 
metabolites and particularly major biologically active quassinoids in crude aqueous 
extracts of Eurycoma longifolia using the Perak samples 
2. To develop a validated NMR method for the quantification of major quassinoids in 
E. longifolia aqueous extracts 
3. To compare the 1H-NMR profiles of aqueous extracts of E. longifolia from four 
different regions in Malaysia 
4. To determine the efficacy of major quassinoids on sperm count increase in rats 
treated with different extracts of E. longifolia containing different quassinoids 
5. To evaluate the post-treatment changes of rat urinary metabolites and fertility status 
without performing semen analysis 
6. To evaluate the post-treatment changes of rat plasma metabolites and fertility status 
without performing semen analysis 
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1.7 Expected outcomes of the current study 
Based on the study objectives the following outcomes were expected: 
1. A standardized general NMR profile of E. longifolia crude aqueous extracts from 
Perak on abundant primary metabolites and major quassinoids as a reference for 
further future research on E. longifolia 
2. NMR-based validated quantification of major quassinoids in E. longifolia 
aqueous extracts 
3. Metabolomic discrimination of aqueous extracts of E. longifolia from Perak, 
Selangor, Kedah and Terengganu 
4. The effectiveness of quassinoids (vs. glycoproteins) in increasing sperm count in 
rats and in general improving male fertility 
5. A non-invasive approach for evaluating male fertility status through urine 
metabolites and without requiring semen analysis 
6. Confirmation of the accuracy of male fertility biomarkers in urine through 
plasma metabolomic analysis 
7. High potential of NMR spectroscopy combined with chemometric tools in the 
discovery of male fertility biomarkers 
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CHAPTER TWO 
LITERATURE REVIEW 
2.1 Eurycoma longifolia Jack 
Eurycoma longifolia Jack, E. longifolia (locally known as Tongkat Ali (TA) or Penawar 
Pahit in Malaysia, Pasak Bumi in Indonesia, Ian-don in Thailand and Cay ba binh in 
Vietnam), is a plant from the family of Simaroubaceae (Kuo et al., 2004). It is an 
unbranched tree or shrub with the height of up to 8 m with a few upright branches which 
are crowned by umbrella-like rosettes of leaves. It grows in well-drained sandy soils 
most effectively (Corner, 1952). The biological information of the plant (Ismail et al., 
1999) together with the plant pictures are included in Fig. 2.1.  
 
2.1.1 Chemical constituents of E. longifolia 
E. longifolia constituents include quassinoids, squalenes, biphenylneolignan, triterpene-
like tirucallanes, canthin-6-one alkaloids, β-carbolines and glycopeptides. Major 
squalene derivatives of E. longifolia include eurylene, 14-deacetyl eurylene, longilene 
peroxide and teurilene (Itokawa et al., 1991a and b; Morita et al., 1993). 
Biphenylneolignan compounds isolated from E. longifolia are two isomeric 2,2’-
dimethoxy-4-(3-hydroxy-1-propenyl)-4’-(1,2,3-trihydroxypropyl) diphenyl ethers, two 
isomers of 2-hydroxy-3,2’,6’-trimethoxy-4’-(2,3-epoxy-1-hydroxypropyl)-5-(3-
hydroxy-1-propenyl)-biphenyl and also 2-hydroxy-3,2’-dimethoxy-4’-(2,3-epoxy-1-
hydroxypropyl)-  
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Fig. 2.1 Eurycoma longifolia Jack; A the whole plant, B leaves, C root and D 
flowers 
hydroxypropyl)- 5-(3-hydroxy-1-propenyl)-biphenyl (Morita et al., 1992). The isolated 
triterpene-like tirucallanes include niloticin, dihydroniloticin, piscidinol A, 
bourjotinolone A, 3-episapelin A, melianone and hispidone (Itokawa et al., 1992). 9,10-
Dimethoxycanthin-6-one, 10-hydroxy-9-methoxycanthin-6-one, 11-hydroxy-10-
methoxycanthin-6-one and 5,9-dimethoxycanthin-6-one are the isloated canthin-6-one 
alkaloids from E. longifolia (Kardono et al., 1991; Mitsunaga et al., 1994; Choo and 
Chan, 2002). β-Carboline derivatives of E. longifolia are β-carboline-1-propionic acid 
and 7-methoxy-β-carboline-1-propionic acid (Kardono et al., 1991; Kuo et al., 2004). A 
biologically active glycopeptide (4.3 kDa) has been isolated from an aqueous extract of 
E. longifolia (Asiah et al., 2007). Most of the therapeutic properties of E. longifolia has 
been attributed to quassinoids as the indigenous phytochemicals of the plant. On the 
other hand, although not evidently proven, Sambandan et al. (2006) attributed the 
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fertility boosting properties of E. longifolia to its glycoprotein content, although 
glycoproteins are the ordinary constituents which may be found in many plant families 
(Galili et al., 1998). As a result, these constituents of E. longifolia (quassinoids and 
glycoprotein) are worthy of further literature search included in the following sections 
(Sections 2.1.1(a) and 2.1.1(b)). 
 
2.1.1(a) Quassinoids 
Quassinoids are the bitter constituents of the plants from the Simaroubaceae family and 
the secondary metabolites characteristic of this family. Nearly 120 quassinoid 
derivatives have been isolated and identified. The term quassinoids is derived from 
quassin which is the first identified member of this class of compounds isolated from the  
specimen Quassia Amara. Quassinoids are chemically defined as highly oxygenated 
degraded triterpenoids derived from tetracyclic triterpenes. They are categorized into 
groups based on their basic skeleton. The basic skeletons of quassinoids include C18, 
C19, C20, C22 and C25 (Fig. 2.2) (Joshi et al., 2013; Nuddin et al., 2015). 
 
Fig. 2.2 Basic skeletons of quassinoids 
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2.1.1(b) Glycoproteins 
2.1.1(b)(i) Glycoproteins in E. longifolia extract 
A biologically-active glycopeptide with the molecular mass 4.3 kDa was previously 
isolated from E. longifolia aqueous extract (Patent No. PI 20003988, MAL; 10/362697, 
USA). According to the patent and some conference presentations, the aphrodisiac and 
fertility boosting properties of E. longifolia aqueous extract has been claimed to be due 
to the glycoprotein (especially the 4.3 kDa glycopeptide) content of this plant to an 
extent where the administration of E. longifolia to rats was reported to increase 
testosterone level in Leydig cells (Sambandan et al., 2006). However, such claims only 
originate from the above-mentioned sources and have not even been published in peer-
reviewed journals, yet (Tambi, 2003; Sambandan et al., 2006). 
As a part of the current research, aqueous extract of E. longifolia (TA water extract, 
TAW) was intentionally depleted of quassinoids to result in a quassinoid-poor TA 
extract (TAQP). The details on the experimental procedure can be found in Section 3.11. 
The TAQP extract could be tested using the chromatographic methods such as high-
performance liquid chromatography (HPLC) to ensure zero or negligible amount of 
quassinoids remaining. However, it was also important to analyze the glycoprotein 
content in both the original extract (TAW) and the one depleted of quassinoids (TAQP) 
to ensure the glycoprotein content of TAQP extract remained intact as that of the TAW 
extract. As a consequence, sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE) was used for such analysis (Section 2.1.1(b)(ii)). 
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2.1.1(b)(ii) Sodium dodecyl sulfate-polyacrylamide gel electrophoresis  
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) has been used 
as a powerful technique for the identification and separation of proteins and 
glycoproteins from plant and tissue samples. In this technique, an electric field is applied 
and the charged molecules in a gel matrix migrate, in response. Proteins and 
glycoproteins, with the molecular weight range of 10–200 kDa, in a complex mixture 
can be separate using this technique. 
Useful information can be derived from the SDS-PAGE analysis. It can be an evidence 
for the presence of glycoproteins in a complex matrix such as plant extract, biological 
fluids, etc. It is also useful in estimating the molecular weight of the glycoprotein.  
A number of staining reagents have been commonly used for the detection of protein 
bands among which Coomassie Briliant Blue, amido black, nigrosine, Procion Blue and 
periodic acid-Schiff (PAS) (Koiw et al., 1952) can be mentioned. A very common 
glycoprotein detection kit is the modification of periodic acid Schiff (PAS) methods 
which yields magenta bands with a light pink or colorless background (Zacharius et al., 
1969; Jay et al., 1990). The detection limit of this technique has been reported in the 
range of 25-100 ng for carbohydrates depending on the nature and the degree of protein 
glycosylation. Horseradish peroxidase has a carbohydrate content of approximately 16% 
and is used as a positive control in the glycoprotein detection kit. 
SDS-PAGE can be performed in the presence of either reducing or nonreducing agents.  
Under reducing conditions, proteins are linearized through the dissociation of inter- and 
intra-chain disulfide bonds. It includes a short heating of the protein sample in a boiling 
water bath in the presence of a reducing agent. The presence of the anionic detergent 
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SDS causes proteins to become coated with a negative charge. The proteins migrate in 
an electric field through the molecular “sieving” action of the gel matrix. As a result, 
they are separated as discrete bands (Racusen 1979). 
 
2.1.2 Therapeutic effects of E. longifolia 
E. longifolia has been traditionally used to treat various ailments including body aches, 
dysentery and glandular swelling (Darise et al., 1982). It has been proven in vitro that E. 
longifolia serves as an antibacterial agent against Gram-positive and Gram-negative 
bacteria (Farouk and Benafri, 2007). It also affects libido and sexual function and serves 
as an aphrodisiac supplement (Ang and Sim, 1997). Furthermore, a wide range of in 
vitro pharmacological properties has been attributed to quassinoids. It includes 
antimalarial (Kuo et al., 2003; Trager and Polonsky, 1981; Kardono et al., 1991; Chan et 
al., 2005), anticancer (Okano et al., 1981; Wong et al., 2012) and antiulcer (Tada et al., 
1991) properties. Moreover, quassinoids and some triterpenes isolated from E. longifolia 
show anti-tumor activities against some type of cancer cells, in vitro (Itokawa et al., 
1992; Jiwajinda et al., 2002). Another in vitro assay showed that a eurycomanone-rich 
fraction of the plant was able to induce cell apoptosis in HepG2 liver cancer (Zakaria et 
al., 2009). In a study performed on human, it was proven that the water-soluble extract 
of E. longifolia root enhanced sperm quality in patients and finally resulted in 14.7% 
spontaneous pregnancies (Tambi and Imran 2010; Tambi et al., 2012). Besides, there are 
also studies on rat models which prove the efficacy of E. longifolia root extracts on 
spermatogenesis and sperm quality (Wahab et al., 2010; Chan et al., 2009). 
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2.2 Male fertility 
Infertility is a worldwide health-related issue influencing 10 to 15 percent of the couples 
(Callister, 2010) in which 8 % of males need to seek medical attention during 
reproductive years (Esteves et al., 2011). Male infertility is among the main leading 
causes of infertility in young adults (World Health Organization, WHO 1999). In 10-20 
percent of the cases, the exact cause of infertility is unidentifiable and unexplained, 
although in general, it may happen as a result of physiological, endocrinal, 
environmental and/or genetic mutations. Surgical and medical treatments are available 
for such conditions. However, the successful treatment of male infertility is difficult and 
unaffordable, to some great extent (Gupta et al., 2013).  
In recent years, many patients have gained interest to natural remedies such as herbal 
supplements to cure infertility. Such supplements are easily obtainable and more cost-
effective than prescription drugs (Rowland and Tai, 2003). Eurycoma longifolia, 
Withania somnifera and Terminalia catappa are among these herbal supplements (Ang 
and Sim, 1997; Sharma et al., 2011; Ratnasooriya and Dharmasiri, 2000). 
Semen analysis is a routine examination of male fertility status through the analysis of 
sperm count, morphology and motility and also blood monitoring of hormones such as 
testosterone, follicle-stimulating hormone (FSH) and luteinizing hormone (LH) (World 
Health Organization, WHO 1999; Dohle et al., 2004). Fertility evaluation is usually 
performed on sperm samples obtained through masturbation that may be awkward and 
inconvenience to the patients. Moreover, blood hormonal investigation is an invasive 
procedure. All these protocols necessitate considering an alternative to investigate 
semen profile (especially sperm count) without requiring semen sample. 
16 
 
2.2.1 Physiology of testis and its functions 
A testis consists of a large number of coiled seminiferous tubules in which spermatozoa 
are produced and then transferred to epididymides. The epididymis is connected to vas 
deferen, which then leads to urethra by passing the prostate gland. Urethra is the last part 
of the reproductive system which connects the whole reproductive system to the exterior 
(Guyton and Hal, 1996). Seminiferous tubules contain different types of germinal cells 
which undergo spermatogenesis. There are spaces between the stacked tubules called 
interstitial tissue which contains lymph vessels, blood vessels and interstitial or Leydig 
cells. These cells produce the major amount of steroid hormones, most importantly 
testosterone.  
The testes functions are to produce male gametes or spermatozoa and male sex 
hormones (androgens). These two functions are closely correlated in that sufficient 
production of androgens is required for the efficient production of spermatozoa 
(Setchell, 1978). 
 
2.2.2 Steroidogenesis and spermatogenesis  
Steroid hormones (androgens) are produced and secreted by testis and required for a 
successful spermatogenesis (Ohkura et al., 2000). Gonadotropin from the anterior 
pituitary regulates the production of androgens. These androgens include testosterone 
(A), dihydrotestosterone (B), 5α-androstan-3β,17β-diol (C), ∆4-androstenedione (D), 
17α-hydroxyperogesterone (E), dehydroepiandrosterone (DHEA) (F), 17α-
hydroxypregnenolone (G), pregnenolone (H), progesterone (I) and oestradiol (J) (Fig. 
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2.3). The building block of all these androgens is cholesterol (Setchell, 1978; Ohkura et 
al., 2000).  
Spermatogenesis is an active replication process which occurs in the seminiferous 
tubules. The mechanism by which spermatozoon (sperm) is produced, is almost the 
same in human and other mammals. In rats, which are the main focus of this research, 
there are roughly 10-20 seminiferous tubules in each testis. Primitive, diploid, stem cell 
spermatogonia finally produce haploid spermatozoa. This process involves a few mitotic 
divisions on the spermatogonia. The last mitotic division leads to the formation of 
spermatocyte. The spermatocyte then undergoes several meiotic cell division, the first 
part of which is spermatocyte DNA duplication during preleptotene stage, chromosome 
pairing and condensing during pachytene stage and eventually culminating in two 
divisions for the production of haploid spermatid. The spermatid undergoes a rapid 
series of morphological changes. The nuclear DNA then gets very condensed and 
elongated to a head region covered by a glycoprotein acrosome coat. The cytoplasm, on 
the other hand, forms a whip-like tail comprising flagellum and mitochondria. The 
sequential morphological steps in the differentiation of the spermatid (19 steps of 
spermatogenesis) is included in Fig.2.4 (OECD, 2001; Cheng and Mruk, 2010). 
The effect of testosterone on maintaining spermatogenesis has been well-documented 
(Steinberger, 1974). Setchell (1978) proved that the administration of high-dose 
testosterone to rats prevented the regression of the seminiferous tubules, a process which 
takes place after hypophysectomy. Furthermore, Steinberger (1970) proved that the 
conversion of gonocytes to type A spermatogonia was regulated by testosterone. 
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Fig. 2.3 The chemical structure of androgens produced in testis 
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Testosterone also enables diakinesis, which is the fifth and last stage of the meiosis 
prophase. Moreover, testosterone plays an active role in the early stages of spermatid 
formation (Steinberger, 1970). 
 
2.2.3 Sperm count 
Sperm count is one of the most critical indicators of male fertility. Any impairments in 
sperm count, due mainly to lifestyle, infection, occupational and environmental hazards 
and genetic mutations can cause infertility (Evens 2004; Parekattil and Agarwal, 2012). 
Normal semen is a mixture of spermatozoa suspended in testicular and epididymal 
secretions. Semen analysis provides a wealth of information on the clinical status of an 
individual. That is the reason why proper care must be taken while collecting and 
analyzing semen. Standardized procedures are available to ensure valid analysis results 
(World Health Organization, 1999). 
There are different categories of semen variables in terms of number of sperm such as 
normospermia (ejaculate with normal sperm concentration based on the reported value 
in the references), oligospermia (ejaculate with less sperm concentration than that of 
reported for normospermia), azoospermia (no spermatozoa in the ejaculate) and 
aspermia (no cjaculate at all) (Eliasson et al., 1970; World Health Organization, 1999; 
Gupta et al., 2013). 
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Fig. 2.4 Drawing depicting the development stages of spermatogenesis in rat 
germ cells (depicted from Cheng and Mruk, 2010) 
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2.3 Comparison of different ‘OMICS’ platforms 
There are different branches of OMICS technology such as metabolomics, genomics and 
transcriptomics as a sub-branch of genomics (Lee et al., 2005). These three OMICS 
technologies together with proteomics form ‘Systems Biology’ (Nicholson and Wilson, 
2003). It is possible through genome sequencing to develop new approaches for 
understanding gene functions. This field of study is known as ‘functional genomics’ 
(Ward and German, 2004). Transcriptomics is about profiling the expression of mRNA 
molecules which are transcribed from the genes. Proteomics, is related to profiling the 
proteins encoded by mRNA molecules. A fact in genomics is that the regulation of gene 
activity is performed on the basis of different levels. Chemical modification of the DNA 
encoding a gene affects its transcription.  
In general, metabolomics is concerned with phenotype and deals with the exhaustive 
profiling of metabolites in an organism. Phenotype is defined as a collection of 
observable characteristics of an individual cell or organism resulting from the interaction 
of genes with the environment (Mahner and Kary, 1997). Proteomics and 
transcriptomics are, however, a flow of media concerning genetic information which do 
not directly indicate gene function. Metabolomics is advantageous over proteomics and 
transcriptomics in that it is a stand-alone field of OMICS which does not require 
genome information. Furthermore, metabolites are a better measure of enzyme activity 
than genes and proteins (Schad et al., 2005; Fukusaki and Kobayashi, 2005). 
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2.4 Metabolomics  
Metabolomics, in general, is defined as the comprehensive evaluation of endogenous 
low-molecular weight metabolites in a biological system which may provide additional 
insight into the molecular mechanisms (Yao et al., 2014). These metabolites are context 
dependent and also different based on the physiological and developmental state of the 
cell, tissue, organ or organism” (Jove et al., 2014). Although the terms metabolomics 
and metabonomics are used interchangeably in the literature, the former is defined as the 
unbiased analysis of all metabolites in a mixture, whereas the latter is the measurement 
of metabolic response to stimuli or genetic modifications (Fiehn, 2001; Fiehn, 2002). 
 
2.4.1 Metabolomics technologies 
Different metabolomic technologies are available, among the most important of which 
GC-MS, LC-MS, FT-IR and NMR can be mentioned (Bino et al., 2004; Schripsema, 
2010). 
GC-MS technique was used for the metabolic analysis of potato tubers. The same 
approach was also employed towards the fast and unbiased comparative multivariate 
analysis of the volatile metabolite composition of different tomato genotypes (Roessner 
et al., 2000; Tikunov et al., 2005). GC-MS technique is also used for the metabolomic 
analysis of biological fluids. Lu et al. (2008) discovered the potential plasma biomarkers 
of hypertension in a rat model through a GC-MS approach. The same approach was used 
to identify the plasma biomarkers of hepatocellular carcinoma in a human model 
(Nezami Ranjbar et al., 2015). In general, there are large GC-MS databases available 
which make the metabolite identification rapid. However, a serious drawback of GC-MS 
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is the fact that metabolites should be volatile for the analysis. Considering the fact that 
high temperatures are applied during the analysis, the metabolites should also be stable. 
As a consequence, less number of metabolites can be detected by GC-MS. The non-
volatile compounds should be derivatized to convert to usable volatile adducts for GC-
MS analysis (Krishnan et al., 2005; Schripsema, 2010). 
Metabolic profiling of transgenic rice plant seedlings was performed through an LC-MS 
method (Mustada et al., 2010). An LC-MS-based approach was employed in another 
study for the global metabolite proﬁling of grapes (Theodoridis et al., 2011). The 
discriminatory metabolites of colorectal cancer (CRC) patients and healthy subjects 
were investigated using an LC-MS-based approach (Fukui and Itoh, 2010). LC-MS was 
employed in another study for detecting low molecular weight metabolite in maternal 
fluid (Luan et al., 2015). In LC-MS analysis, metabolites can be separated by LC and 
subsequently analyzed by MS. High–resolution spectra can be obtained using modern 
LC columns. However, the problem with the use of LC-MS is that large and 
comprehensive databases do not exist, yet. Besides, all the techniques coupled to MS are 
intrinsically biased against special classes of compounds. For instance, when the MS 
ionization mode is electrospray (ESI) in LC-MS, simple terpenes, carotenoids and 
aliphatics are semi-inert and these compounds cannot be detected successfully by the 
analytical method. The effects of ion suppression due to matrix effect is another 
drawback which should not be denied (Sterner et al., 2000; Choi et al., 2001; 
Weckwerth, 2003). 
FT-IR has also been extensively studied in the field of metabolomics. Wu et al. (2008) 
successfully managed to perform a rapid discrimination of two similar natural products, 
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the extracts of Chinese propolis and poplar buds, by this technique. A FT-IR 
metabolomics fingerprinting approach was performed to analyze the interactions 
between structural variants of N-alkyltropinium bromide surfactants with the Gram 
negative and the Gram positive bacteria. The metabolomic damage exerted by these 
compounds was then determined (Corte et al., 2015). Furthermore, FT-IR was also used 
for the metabolomic analysis of lyophilized and fresh Saccharomyces cerevisiae yeast 
cells. The FT-IR spectral data provided interesting and informative data on the 
metabolic status of the whole yeast cell (Correa-García et al., 2014). FT-IR has both 
benefits and drawbacks. It is a non-destructive, simple and fast method with high 
repeatability. The IR spectrum of a speciﬁc chemical compound is unique due to the 
unique bonding arrangements and functional groups. However, despite the usefulness of 
FT-IR in the identification of the metabolites in a mixture and its being as a requisite 
method in the Pharmacopoeia, some limitations exist in the identification of unknown 
compounds in such a way that the metabolite identification is only possible if the FT-IR 
spectrum of the pure compound is available as a reference for further analysis. As a 
result, this technique lacks a comprehensive database of metabolites (Levine et al., 
1989; Wu et al., 2008). 
There are myriad of advantages to the use of NMR spectroscopy in the field of 
metabolomics. One of the major benefits of NMR is its robustness and the lack of 
sample pre-treatment (separation/fractionation) which reduces the analysis time to a 
great extent. NMR is a quantitative and non-destructive approach which provides a 
complete and comprehensive picture of the whole metabolome in a way that no 
metabolite is lost in the matrix, although some metabolites might be represented by only 
